News Focus
News Focus
icon url

eb0783

02/17/17 11:49 PM

#286453 RE: elleryqueen #286448

This is not about financial reports.

I wish I had the time to read the financial reports

You should know that. The value of any company that has not yet commercialized their product has very little connection to financial reports. Until the baby is born.......

this is another CTIC

This is your next opportunity to

made a boat load of money

icon url

entdoc

02/18/17 1:17 AM

#286462 RE: elleryqueen #286448

Dear E Queen, if you bought at .29, and sold now, you would realize a gain greater than 99.9% of the stockholders who have been here 1-20 years. PPHM does seem to have a lot to do with cancer, as you suggested in your post, but also appears to be rapidly expanding into other healthcare fields such as early diagnosis of cancer; cancer recurrence diagnosis; chronic inflammatory diseases and aging....if there is a difference.
The best thing PPHM has going for it is its survival record, and its worst liability is a non-forward-looking board of directors. If you want to double down now on your investment there are any number of folks who would be grateful for your contribution to the science. PPHM track record suggests that it is an ultra long-term investment. I've been here for 20 years, and have enormous paper losses to show for it.
Yours ever-hopeful, ENT doc.